International postcards and domestic postcards went up in price as well. The United States Postal Service said the price adjustments are “needed to achieve the financial stability.” A long-acting flea ...

Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick infestations on dogs for a duration of ...

Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., ...

Rahway, New Jersey Saturday, July 12, 2025, 09:00 Hrs [IST] ...

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...

Bravecto Quantum delivers the first injectable fluralaner dose that shields a dog from flea and tick infestations for a full year. One visit replaces eleven ...

The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ...

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...

The U.S. Food and Drug Administration (FDA) approved Bravecto Quantum, a novel injectable treatment offering dogs up to 12 months of protection against fleas and ticks with a single dose.

The FDA has approved a long-acting drug to protect dogs against fleas and ticks. The drug, Bravecto Quantum, is given by injection and must be prescribed by a licensed veterinarian.

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.